Progyny Inc

Progyny Inc Stock Forecast & Price Prediction

Live Progyny Inc Stock (PGNY) Price
$40.78

5

Ratings

  • Buy 5
  • Hold 0
  • Sell 0
Disclaimer : The analyst ratings and price forecast data are provided by Tradefeeds. The data is sourced from Wall Street analysts and other experienced experts. The figures presented are solely a forecast and not a guarantee of future price performance. The information presented is not a recommendation to buy or sell the stock.

Stock Price

$40.78

P/E Ratio

79.96

Volume Traded Today

$854,400

Dividend

Dividends not available for PGNY

52 Week High/low

44.95/29.44

Progyny Inc Market Cap

$3.91B

🛑 Alert: These ten stocks could have higher potential than $PGNY 🛑

Before you buy PGNY you’ll want to see this list of ten stocks that have huge potential. Want to see if PGNY made the cut? Enter your email below

PGNY Summary

Based on ratings from 5 stock analysts, the Progyny Inc stock price is expected to increase by 13.78% in 12 months. This is calculated by using the average 12-month stock price forecast for Progyny Inc. The lowest target is $43.00 and the highest is $49.00. Please note analyst price targets are not guaranteed and could be missed completely.

PGNY Analyst Ratings

About 5 Wall Street analysts have assignedPGNY 5 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Progyny Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on PGNY. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.

PGNY stock forecast by analyst

Analyst/Firm

Rating

Price Target

Change

Date

jailendra singh
Truist Financial

Buy

$47.0

maintained

Jan 4, 2024
stephanie davis
Barclays

Buy

$48.0

initiatedcoverage

Jan 2, 2024
david larsen
BTIG

Buy

$45.0

maintained

Dec 28, 2023
glen santangelo
Jefferies

Buy

$43.0

reiterated

Nov 30, 2023
anne samuel
J.P. Morgan

Buy

$49.0

rated

Nov 20, 2023
scott schoenhaus
KeyBanc

Buy

$45.0

maintained

Nov 8, 2023
allen lutz
Bank of America Securities

Buy

$47.0

reiterated

Nov 8, 2023
richard close
Canaccord Genuity

Buy

$46.0

maintained

Nov 7, 2023
michael cherny
Bank of America Securities

Buy

$51.0

reiterated

Aug 4, 2023
sarah james
Cantor Fitzgerald

Buy

$45.0

maintained

May 9, 2023
dev weerasuriya
Berenberg Bank

Buy

$55.0

initiatedcoverage

Nov 18, 2022
iris long
Berenberg Bank

Buy

$80.0

reiterated

Nov 5, 2021
stephen tanal
SVB Securities

Buy

$50.0

maintained

Nov 6, 2020
daniel grosslight
Citigroup

Buy

$28.0

initiatedcoverage

Nov 19, 2019

PGNY Company Information

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

PGNY
Progyny Inc (PGNY)

When did it IPO

2019

Staff Count

393

Country

United States

Sector/Industry

Healthcare/Health Information Services

CEO

Mr. Peter Anevski

Market Cap

$3.91B

Progyny Inc (PGNY) Financial Data

In 2023, PGNY generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that PGNY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

N/A

0.00 %
From Previous Year

Revenue From 2022

N/A

0.00 %
From Previous Year

Revenue From 2023

N/A

0.00 %
From Previous Year
  • Revenue TTM $1.03B
  • Operating Margin TTM 6.5%
  • Gross profit TTM $167.3M
  • Return on assets TTM 5.2%
  • Return on equity TTM 12.1%
  • Profit Margin 5.0%
  • Book Value Per Share 5.38%
  • Market capitalisation $3.91B
  • Revenue for 2021 N/A
  • Revenue for 2022 N/A
  • Revenue for 2023 N/A
  • EPS this year (TTM) $0.51

Progyny Inc (PGNY) Latest News

... ...

Similar Stocks to Progyny Inc - PGNY

🛑 Alert: These ten stocks could have higher potential than $PGNY 🛑

Before you buy PGNY you’ll want to see this list of ten stocks that have huge potential. Want to see if PGNY made the cut? Enter your email below

...

PGNY Frequently asked questions

The highest forecasted price for PGNY is $49.00 from anne samuel at J.P. Morgan.

The lowest forecasted price for PGNY is $43.00 from glen santangelo from Jefferies

The PGNY analyst ratings consensus are 5 buy ratings, 0 hold ratings, and 0 sell ratings.